Melsoma Nano Spray 12 ml

babies: melsoma solution is unsafe, and it is not recommended under 18 years of children. lactating mother: melsoma is safe if prescribed by your doctor.
studies have shown evidence of risk to developing babies. pregnancy: consult your doctor because no studies have shown evidence of side effects to the baby.
driving: melsoma solution may cause alertness and affect vision. do not drive if these occur.
alcohol: alcohol consumption is unsafe while taking this solution because it may cause drowsiness or decreased alertness. kidney: consult your doctor.
studies have shown inadequate evidence in patients with kidney disease. liver: melsoma solution should be used caution in patients with liver disease.
.

abdominal cramps decreased alertness dizziness drowsiness headache irritability fatigue circadian rhythm disruption .

melsoma solution is a natural hormone. it works by reducing the abnormal activity of nerves in the brain & regulates the sleep-wake cycle, and improved quality of life.
.

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• take this solution in dose and frequency as directed by your doctor. • should not be taken on an empty stomach.
• shake well before use. • measure with a measuring cup and take it by mouth.
• do not stop or continue the course unless told by your doctor. • avoid alcohol consumption while taking the solution, as it may cause drowsiness and decreased alertness.
• avoid caffeine products at night time. .

serious • melsoma + abametapir: concurrent use leads to an increase in melsoma levels by decreasing abametapir. • melsoma + givosiran: concurrent use leads to an increase in melsoma levels by a decrease in givosiran.
monitor closely • melsoma + amitriptyline: concurrent use leads to sedation. • melsoma + antithrombin iii: concurrent use leads to a decrease in melsoma levels by increasing antithrombin iii.
• melsoma + clonazepam: concurrent use leads to increase sedation. • melsoma + diazepam: concurrent use leads to increases in sedation.
• melsoma + ibuprofen: concurrent use leads to an increase in ibuprofen levels by decreasing melsoma. • melsoma + mefenamic acid: concurrent use leads to an increase in mefenamic acid by decreasing melsoma.
minor • melsoma + atenolol: concurrent use of melsoma leads to decreases toxicity of atenolol. • melsoma + timolol: concurrent use of melsoma leads to decreases toxicity of timolol.
.